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The causes of periparturient (PP) E.coli mastitis in lactating cows are complex and multifactorial 
(Burvenich et al., 2007). The disease is accompanied by a large variation in clinical symptoms 
varying from mild/moderate, to severe life-threatening sepsis. There is a small subpopulation of 
severely affected cows that suffer from unbalanced inflammation. It is now accepted that 
severity of PP E.coli mastitis is mainly determined by cow factors (Burvenich et al., 2003). 
Studies on isolated blood neutrophils (PMN) of healthy cows before intramammary infection with 
alive E.coli bacteria, showed that chemotaxis (Lohuis et al., 1990; Kremer et al., 1993) and the 
capacity to produce reactive oxygen species (Heyneman et al., 1990) before challenge is 
negatively correlated with severity and positively with pathogen elimination. At least three major 
issues can be discerned from these studies: (I) the role of the alteration of pre-infection PMN 
function in the outcome of PP E.coli mastitis. Since the nineties many studies have contributed 
to the understanding of the alteration of PP PMN function and viability. In vitro effects of non-
esterified fatty acids, beta hydroxybutyrate, estradiol, progesterone, glucocorticoids and IGF 
were studied (Lamote et al., 2004; Scalia et al., 2006; Sander et al., 2011). (II) The study of 
potential links with other diseases during the same period. The PP period is a critical period for 
animal welfare and dairy economics. (III) Identification of one or more biomarkers (BM) to 
characterize E.coli mastitis specifically and their potential role in the management and health 
care of cows in general. In contrast to the afore-mentioned issues only a few studies are dealing 
with predictability of severity of PP diseases. This review will analyze some historical studies for 
potential BM discovery based on PMN function and relating gene expression to its phenotypic 
outcome (e.g.: CD11/CD18, alkalin phosphatase by van Werven et al., 1997, CD25-expression 
by Zoldan et al., 2014, and serum proteomics by Cairoli et al., 2006). It will also focus on 
genome- and epigenome- based tools and discusses advantages, limitations and future 
prospects. The potential utility of BM in experimental research and/or field studies will also be 
highlighted (see Figure 1).  
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INTRODUCTION  
Environmental E.coli bacteria are one of the most common etiologic agents isolated from clinical periparturient (PP) mastitis in well-managed farms. 
More than 50% of all clinical mastitis cases occur during the first eight weeks after calving. Although E.coli strains may influence the severity of infection, 
the primary determinant of severity is the physiological state of the cow. Severe PP E.coli mastitis is associated with a pre-infection history of neutrophil 
(PMN, Table 1 & 2) and mononuclear cell (MN) compromisation. Experimental challenge of the PP mammary gland with opportunistic E.coli bacteria 
has shown to be a good model to estimate suppressed immune competence during the first weeks of lactation (1). Next to this, reduced liver function 
has also been detected (3) as well as changes in serum proteomics (6). PP environmental mastitis is also linked with other infection diseases during the 
same period (e.g. metritis). The PP period is therefore a critical period for animal welfare and dairy economics.  
An overwhelming amount of evidence of PP immune dysfunction has been generated by many researchers worldwide. A large amount of data have 
been collected since 1990. Nevertheless, only a small subpopulation of PP cows with E.coli mastitis suffer from unbalanced inflammation (sepsis, see 
Fig. 1). The data can be used to discover and to evaluate potential PP biomarkers. The goal would be to provide relevant information about: 1) PP 
immune dysfunction (risk biomarker) and/or 2) outcome of PP infection diseases (prognostic biomarker). The in vivo mammary E.coli challenge and in 
vitro stimulation of isolated neutrophils are assays that provide accurate data within a large phenotypic variation. In this “simplified preliminary report” we 
show how the afore-mentioned data of PMN function, gene expression and phenotype can be integrated into a valuable model to study BM (Fig. 2).  
OBJECTIVE 
         Phenotypic severity variation (Fig. 1) 
PP E.coli mastitis (2 cfu loads; A heifer, B multiparous)  
   Correlation severity phenotype & pre-infection function  
 PMN reactive oxygen species, ROS (Table 1)         PMN chemotaxis (Table 2) 
RESULTS 
Genes related to production of ROS during phagocytosis, and chemotaxis 
Perturbations in PMN functions during PP are accompanied by modulation of the expression of 
TLR4 pathway genes (TRAF6, ATF3, RELA, IL8, and C5aR are lower during PP). C5a and TLR4 
signaling in PMN may provide positive feedback promoting severe mastitis. C5a seems to be a 
critical early mediator in the development of severe E. coli mastitis (5). Boulougouris et al. (2015) 
Poster presentation “Innate Immune Memory Conference, March 18-20, 2015, Welcome trust Cambridge, UK” is 
studying the expression of eight genes involved in ROS-production: CAT, SOD2, CYBB, CYBA, 
NCF1, RAC1, RAC2 and NCF4 and their epigenetic regulation. Multiple genes or their isoforms can 
potentially alter gene function and thus be used as BM (4). However, no isoforms were detected in 
the afore-mentioned eight genes.  
Day  0               R = - 0.60 
Day +1              R = - 0.72 
Day +2              R = - 0.74 
Day +5              R = - 0.92 
Day +6              R =  NS  
Kremer et al., 1993 
Day +1 (O2- nmoles x PMN) 
Zymosan induced ROS synthesis 
R = - 0.90 
PMA induced O2- ROS synthesis 
R = - 0. 77 
Heyneman et al., 1990 
Hormones and metabolites affect several PMN functions and epigenesis 
Neutrophils from PP cows have altered gene expression profiles which are linked to inappropriate 
responses upon an intramammary E.coli infection. Epigenetic mechanisms such as DNA 
methylation, histone modification and microRNAs have key functions in the regulation of gene 
expression (2). Growth hormone, estradiol, progesteron, glucocorticosteroids, insuline like growth 
factor - IGF, cathecholamines, nonesterified fatty acids and beta-hydroxybutyrate affect PMN 
function and viability (1).  
This simplified model shows potential adoption of gene, epigene and/or phenotype data as BM. More data have to be included to obtain a complete 
picture. To what extent identification of cows at risk for a short period would enable a more targeted intervention have to be discussed. The model can be 
adapted to non-neutrophil cells (e.g. mononuclear cells) and BM in blood or milk as far as they participate in the pathogenesis of E.coli mastitis.  
CONCLUSION 
(F
ig
. 2
) 
Small subpopulation of 
PP cows suffering from 
severe clinical E.coli 
mastitis (sepsis). 
Heyneman et al., 1990 
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